LMR Partners’s Tectonic Therapeutic TECX Stock Holding History

LMR Partners’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,502	Closed	-$12K	–	1300
2022 Q3	$12K	Hold	1,502	–	–	﹤0.01%	1185
2022 Q2	$17K	Buy	+1,502	New	+$17.7K	﹤0.01%	1243

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LMR Partners's TECX Position: Q4 2022 in Review

LMR Partners sold out of Tectonic Therapeutic (TECX) in Q4 2022, closing a stake of 1,502 shares — an estimated $12K sold.

LMR Partners first reported a position in TECX in Q2 2022 and held it in 2 quarters. The position peaked at $17K in Q2 2022. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2022.

LMR Partners reported no remaining Tectonic Therapeutic position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 1,502 Tectonic Therapeutic shares in Q4 2022, an estimated $12K.
LMR Partners first reported a position in Tectonic Therapeutic in Q2 2022 and held it in 2 quarters.
LMR Partners's Tectonic Therapeutic position peaked at $17K in Q2 2022.
45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.